Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease

NCT00437125 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00437125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00437125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
July 31, 2009
Enrollment
151 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson disease, major depressive disorder